MREO

Conviction 18HealthcareScan · Thu, Jun 25, 2026

MREO$0.3097+1.81%

ResistanceSupportVol 14

Vol MA14 2.03M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Mereo BioPharma Group plcPHARMACEUTICAL PREPARATIONSwww.mereobiopharma.com ↗

Price0.3097

Change+1.81%

Gap+0.69%

Rel volume0.09×

Avg volume3.01M

Avg $ vol967.5K

SMA 200.3151

SMA 500.2949

SMA 2000.9743

Price vs 50+5.02%

Price vs 200-68.21%

MA stackmixed

50/200 cross—

Supertrendup · 0.2364

RSI (14)51

MACD hist-0.00

MACD crossbear · 1d

Stoch %K / %D51 / 45

ADX (14)27

+DI / −DI17 / 15

RSI divergence—

MACD divergenceBearish

ATR %+9.95%

ADR %9.80%

52w high2.94

52w low0.2372

From 52w high-89.47%

Above 52w low+30.56%

New 52w highNo

SqueezeOn · 6d

Bollinger width18.86%

%B0.41

Donchian pos34.58%

Donchian high0.3655

Donchian low0.2802

AVWAP (52w high)0.6779

vs AVWAP high-54.32%

AVWAP (52w low)0.3993

vs AVWAP low-22.44%

OBV trendDown

Chaikin MF (20)0.05

Today vs 20d0.09×

Avg vol (14d)2.03M

Avg vol (20d)3.01M

Avg $ vol (20d)967.5K

Market cap247.17M

RS 3m (vs SPY)-21.72%

RS 6m (vs SPY)-92.53%

RS line new highNo

Trend template2/8

Technical rank19.7

1 week-0.10%

1 month-7.19%

3 months-11.46%

6 months-86.48%

1 year-88.61%

YTD-39.32%

P/E-5.90

P/B7.26

P/S494.34

P/FCF-7.98

EPS-0.0500

Div yield—

ROE-122.98%

ROA-103.11%

Debt/Eq—

Current6.48

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth3.18%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value210.95M

Revenue0

Net income-6.72M

Gross profit—

Free cash flow-30.99M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out159.62M

Employees39

ListedTue, Apr 24, 2018

Free float798.09M

Float %100.0%

Short interest8.16M

Days to cover0.7d

Short volume19.9%

Squeeze score6 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank19.7 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.3649

Support0.2231

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MREO

All disclosures →

No recent disclosed trades by Congress in MREO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MREO

No recent insider (Form 4) filings in MREO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in MREO

EDGAR →

No recent SEC filings on file for MREO.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.